Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biotech Vaneck ETF (BBH)

Biotech Vaneck ETF (BBH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 494,439,700
  • Shares Outstanding, K 2,822
  • 60-Month Beta 0.90
Trade BBH with:
  • Price/Earnings ttm 26.71
  • Annual Dividend & Yield 0.61
  • Most Recent Dividend 0.608
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview

Details
  • Implied Volatility 21.61%
  • Historical Volatility 22.95%
  • IV Percentile 2%
  • IV Rank 4.22%
  • IV High 38.85% on 04/21/20
  • IV Low 20.85% on 04/06/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5
  • Volume Avg (30-Day) 10
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 5

Price Performance

See More
Period Period Low Period High Performance
1-Month
168.43 +5.40%
on 03/25/21
182.28 -2.61%
on 03/22/21
+3.50 (+2.01%)
since 03/12/21
3-Month
163.63 +8.49%
on 03/05/21
197.28 -10.02%
on 02/16/21
-0.54 (-0.30%)
since 01/13/21
52-Week
136.96 +29.61%
on 04/15/20
197.28 -10.02%
on 02/16/21
+41.28 (+30.30%)
since 04/13/20

Most Recent Stories

More News
Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

AZN : 49.06 (-0.73%)
PFE : 36.99 (+0.05%)
MRNA : 147.97 (+6.15%)
NVAX : 197.34 (+12.35%)
IBB : 147.40 (+0.61%)
XBI : 126.71 (-0.27%)
BBH : 177.52 (+1.18%)
FBT : 157.46 (-0.13%)
BTEC : 56.36 (+0.48%)
BNTX : 127.55 (+4.96%)
Moderna ETFs to Gain on Positive 'Real-World' Study Data

Positive coronavirus vaccine progress by Moderna (MRNA) grabs investors' attention.

PFE : 36.99 (+0.05%)
MRNA : 147.97 (+6.15%)
IBB : 147.40 (+0.61%)
BBH : 177.52 (+1.18%)
BTEC : 56.36 (+0.48%)
GERM : 34.92 (+2.40%)
Will ETFs Gain on AstraZeneca's Latest Covid-19 Vaccine Update?

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence thanks to multiple mutants.

AZN : 49.06 (-0.73%)
MRNA : 147.97 (+6.15%)
NVAX : 197.34 (+12.35%)
IBB : 147.40 (+0.61%)
CNCR : 28.23 (+1.15%)
XBI : 126.71 (-0.27%)
PPH : 67.69 (-0.67%)
BBH : 177.52 (+1.18%)
Novavax ETFs to Shine Bright on Positive Vaccine Update

Investors are closely tracking the progress in coronavirus vaccine development and distribution amid the pandemic.

JNJ : 158.19 (-2.13%)
NVAX : 197.34 (+12.35%)
IBB : 147.40 (+0.61%)
XBI : 126.71 (-0.27%)
BBH : 177.52 (+1.18%)
GERM : 34.92 (+2.40%)
ETFs to Tap Amgen's Drive for Cancer Deal

Amgen (AMGN) has agreed to buy Five Prime Therapeutics (FPRX) for $1.9 billion.

BMY : 63.19 (+0.80%)
AMGN : 247.58 (-0.55%)
IBB : 147.40 (+0.61%)
FPRX : 37.96 (-0.03%)
BBH : 177.52 (+1.18%)
PJP : 77.61 (-0.23%)
IEIH : 31.80 (+0.06%)
How Will Biotech ETFs React to These Q4 Earnings Releases?

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry post their fourth-quarter earnings releases amid the coronavirus crisis.

BIIB : 263.43 (+0.24%)
ALXN : 153.35 (-0.43%)
GILD : 64.56 (-0.15%)
AMGN : 247.58 (-0.55%)
IBB : 147.40 (+0.61%)
XBI : 126.71 (-0.27%)
BBH : 177.52 (+1.18%)
Novavax (NVAX) ETFs to Rise on Impressive Coronavirus Vaccine Update

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

MRNA : 147.97 (+6.15%)
NVAX : 197.34 (+12.35%)
IBB : 147.40 (+0.61%)
XBI : 126.71 (-0.27%)
BBH : 177.52 (+1.18%)
GERM : 34.92 (+2.40%)
Can Moderna ETFs Gain on COVID Vaccine Update Against Variants?

Positive coronavirus vaccine update from Moderna (MRNA) has hogged investors' attention.

MRNA : 147.97 (+6.15%)
IBB : 147.40 (+0.61%)
XBI : 126.71 (-0.27%)
BBH : 177.52 (+1.18%)
BTEC : 56.36 (+0.48%)
GERM : 34.92 (+2.40%)
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

PFE : 36.99 (+0.05%)
MRNA : 147.97 (+6.15%)
LLY : 182.10 (+0.15%)
IBB : 147.40 (+0.61%)
CNCR : 28.23 (+1.15%)
XBI : 126.71 (-0.27%)
BBH : 177.52 (+1.18%)
FBT : 157.46 (-0.13%)
SBIO : 46.13 (-0.86%)
PBE : 72.52 (+0.25%)
BTEC : 56.36 (+0.48%)
ARKG : 87.69 (+1.24%)
BNTX : 127.55 (+4.96%)
ETFs to Tap AstraZeneca Mega-Deal to Buy Alexion

AstraZeneca has agreed to buy rare-disease specialist Alexion Pharmaceuticals for $39 billion. The deal would represent the biggest transaction in pharmaceuticals since 2019.

ALXN : 153.35 (-0.43%)
AZN : 49.06 (-0.73%)
PPH : 67.69 (-0.67%)
BBH : 177.52 (+1.18%)
FBT : 157.46 (-0.13%)
PJP : 77.61 (-0.23%)
PBE : 72.52 (+0.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of...

See More

Key Turning Points

3rd Resistance Point 181.02
2nd Resistance Point 179.38
1st Resistance Point 177.41
Last Price 177.52
1st Support Level 173.80
2nd Support Level 172.16
3rd Support Level 170.19

See More

52-Week High 197.28
Last Price 177.52
Fibonacci 61.8% 174.24
Fibonacci 50% 167.12
Fibonacci 38.2% 160.00
52-Week Low 136.96

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar